DNAPrint Announces Participation in Knobias.com 'Corporate Tour 1000' Campaign
SARASOTA, Fla.--(BUSINESS WIRE)--May 25, 2001--DNAPrint Genomics, Inc. (OTCBB:DNAP) announced today its participation in the Knobias.com "Corporate Tour 1000" campaign. The campaign includes the publication of a "Corporate Tour" video that will allow DNAPrint to show individual investors, as well as institutional investors, the company's facilities, management and company operations via the Knobias.com web site in streaming media format. The video tour is presently available for viewing at knobias.com.
"Knobias.com is pleased to have DNAPrint Genomics as a participant in the 'Corporate Tour 1000' campaign," stated Greg Ballard, Knobias COO. "I feel companies are beginning to realize the value of 'third party,' unbiased exposure to the investing community. Knobias.com, originally launched as pennyPI.com and relaunched as www.knobias.com on February 16, 2001, will facilitate the distribution of this content to the commercial markets. We have had tremendous interest from the institutional market for our data." About DNAPrint Genomics:
DNAPrint Genomics Inc. was founded by a team of scientists with research and commercial experience in high-level mathematical modeling, programming and molecular genetics. The Company is traded on the NASDAQ OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com About Knobias.com:
Knobias.com, a privately owned Mississippi based Internet company, is the first and largest online resource for unbiased knowledge covering the "Outside Markets." Knobias.com currently maintains the Web's largest electronic database of unbiased, current and historical research on 6,000+ "Outside Market" companies. These "Outside Market" companies include those with little traditional coverage that trade publicly on the OTCBB, the Pink Sheets, and the NASDAQ Small Cap market.
As a policy of complete independence, Knobias.com has not received any compensation from the Company mentioned herein for the Corporate Tour Video nor does it hold a position in this security. Knobias.com has absolutely no affiliations, material or otherwise, with any company mentioned herein. For more information regarding Knobias.com please visit their web site www.knobias.com or email at info@knobias.com, or call 601/978-3399.
All statements in this press release that are not historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint Genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
CONTACT: DNAPrint Genomics Inc., Sarasota
For scientific inquiries:
Dr. Tony Frudakis, 941/351-4543 |
